Is TB-500 Legal in Washington State? How to Access It Legally

See the public record for TB-500

  • What it is / A synthetic 7-amino-acid fragment of the 43-amino-acid protein thymosin beta-4, not the full-length protein [1]
  • FDA approval / None; no approved product in the US or in any country FDA checked [1]
  • FDA compounding lists / Not on them; in none of the three interim-policy categories [2][6][3]
  • Advisory committee / Voted July 23, 2026 to recommend adding it, against FDA staff's advice; non-binding [7][4]
  • HHS draft policy / Draft, non-binding enforcement discretion for TB-500 acetate by injection, filed October 28, 2026 [4][5]
  • Human data / No study found in which TB-500 was given to a person [1]
  • Sport / Prohibited at all times under WADA S2.3 [8][9]

Is TB-500 approved or on a compounding list?

No. FDA's July 2026 review found no USP or National Formulary monograph for TB-500, no approved drug containing it, and no approved product in Canada, Australia, the UK, Belgium, Ireland, France, Norway, Germany, Spain or Italy, and no product authorized by the European Medicines Agency [1]. TB-500 appears in none of the three categories on FDA's list for state-licensed pharmacies and physicians (updated May 14, 2026) or on FDA's list for outsourcing facilities (updated March 21, 2025) [2][6][3]. FDA found no pharmacy marketing a compounded TB-500 product and no outsourcing facility reporting one [1].

It does appear on FDA's safety-risk page, in the 'nominated but withdrawn' table, which holds substances previously in category 2 whose nominators withdrew them; it is not in the active category 2 table [10]. Removal from category 2 was not a finding of safety [10].

What changed in 2026

FDA's Pharmacy Compounding Advisory Committee reviewed TB-500 free base and TB-500 acetate on July 23, 2026 and voted in favor of adding it to the bulks list, against FDA staff's recommendation [7][4]. The advice is non-binding and listing takes formal rulemaking [7][4]. FDA staff had proposed that neither form be added, citing no evidence of effectiveness for wound healing, inconsistent naming, missing impurity and endotoxin data, and immunogenicity risk for injection [1].

A draft HHS enforcement-discretion policy filed October 28, 2026 (Federal Register document 2026-22192, publication scheduled October 30, 2026) names TB-500 among six peptides and covers TB-500 acetate given by subcutaneous or intramuscular injection [4][5]. HHS says it does not intend to take enforcement action against a state-licensed pharmacy, federal facility or licensed physician compounding with it if the policy's conditions are met, such as a single active ingredient, a patient-specific prescription and an FDA-registered manufacturer with a certificate of analysis [4][5]. The notice says it establishes no rights, is not binding on HHS or the public, and may be revisited if a safety signal or quality issue arises [4].

What is known about safety

There is no approved dose, and FDA found no human pharmacokinetic or pharmacodynamic data [1]. FDA also found no nonclinical toxicity studies, and its stated concern for an injected peptide like this is immunogenicity, potentially amplified by aggregation and impurities [1]. In an in-vitro scratch-wound test, TB-500 at 50 microgram/mL did not induce wound closure in fibroblast cultures, while a shorter metabolite did [1]. FDA's adverse-event database search through March 26, 2025 retrieved no TB-500 reports, and its food and supplement complaint system retrieved two cases involving a blended TB-500 and BPC-157 product with no safety assessment [1]. In FDA's BPC-157 review, a 40-year-old woman using a research-use BPC-157 plus TB-500 (5 mg/5 mg) injectable twice daily developed widespread skin hyperpigmentation and gum darkening within a week, recurring when she retried it; because the product held two peptides, FDA could not tell whether either caused it [11].

What this means in Washington

The federal position described above is the one this page can establish. FDA says state-licensed physicians and pharmacists compounding under the federal rules may only use bulk substances that meet a USP or National Formulary monograph, are components of an approved drug, or are on FDA's bulks list [3]. TB-500 meets none of these, and the HHS policy is a non-binding draft that establishes no rights [1][3][4]. No Washington-specific rule on TB-500 is identified here, so nothing on this page shows a state pathway.

Athletes

WADA names 'Thymosin-beta4 and its derivatives e.g. TB-500' in S2.3, prohibited at all times, in and out of competition, on the 2026 and 2027 Lists [8][9].

Is TB-500 legal in Washington state?
TB-500 is not an approved prescription drug and is not covered by FDA's current compounding lists [1][2][3]. The HHS draft policy says HHS does not intend to take enforcement action against specified entities using TB-500 acetate by injection if stated conditions are met, but the policy is non-binding, establishes no rights and is not an approval [4][5]. No Washington-specific rule on TB-500 is identified on this page.
Can a Washington doctor prescribe compounded TB-500?
FDA says a compounder may only use a bulk substance that has a USP or National Formulary monograph, is a component of an approved drug, or is on FDA's bulks list, and TB-500 meets none of these [1][3]. The HHS draft policy would, if finalized as written, have HHS refrain from enforcement against a licensed physician or state-licensed pharmacy that meets its conditions, but it is non-binding and not an approval [4][5]. FDA found no pharmacy marketing a compounded TB-500 product and no outsourcing facility reporting one [1].
Did the July 2026 advisory committee vote make TB-500 legal?
No. The committee voted in favor of adding it to the bulks list against FDA staff's recommendation, but the advice is non-binding and listing takes formal rulemaking [7][4]. FDA staff had proposed that neither the free base nor the acetate be added [1].
Has TB-500 ever been tested in people?
FDA found no study in which TB-500 was given to a human [1]. Studies of full-length thymosin beta-4 tested a different molecule and do not show that this 7-amino-acid fragment works or is safe [1].
Is TB-500 banned in sport?
Yes. WADA's Prohibited List names Thymosin-beta4 and its derivatives e.g. TB-500 in S2.3 and prohibits them at all times, in and out of competition, on both the 2026 and 2027 Lists [8][9].
Show all 11 referencesHide references
Evidence overview for Is TB-500 Legal in Washington State? How to Access It Legally